These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 24073461)

  • 21. Towards the elimination of lymphatic filariasis.
    Dean M
    Lancet; 2002 May; 359(9318):1677. PubMed ID: 12020539
    [No Abstract]   [Full Text] [Related]  

  • 22. Elimination of lymphatic filariasis in South East Asia.
    Specht S; Suma TK; Pedrique B; Hoerauf A
    BMJ; 2019 Jan; 364():k5198. PubMed ID: 30670373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymphatic filariasis elimination: progress in global programme development.
    Molyneux DH; Zagaria N
    Ann Trop Med Parasitol; 2002 Dec; 96 Suppl 2():S15-40. PubMed ID: 12630391
    [No Abstract]   [Full Text] [Related]  

  • 24. Lymphatic filariasis in kenya since 1910, and the prospects for its elimination: a review.
    Wamae CN; Mwandawiro C; Wambayi E; Njenga S; Kiliku F
    East Afr Med J; 2001 Nov; 78(11):595-603. PubMed ID: 12219966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Editorial: Global elimination of lymphatic filariasis: fact or fantasy?
    Gyapong JO; Twum-Danso NA
    Trop Med Int Health; 2006 Feb; 11(2):125-8. PubMed ID: 16451335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preventing confusion about side effects in a campaign to eliminate lymphatic filariasis.
    Ramaiah KD; Ravi R; Das PK
    Trends Parasitol; 2005 Jul; 21(7):307-8. PubMed ID: 15923141
    [No Abstract]   [Full Text] [Related]  

  • 27. Towards elimination of lymphatic filariasis in India.
    Das PK; Ramaiah KD; Augustin DJ; Kumar A
    Trends Parasitol; 2001 Oct; 17(10):457-60. PubMed ID: 11587940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Global Programme to Eliminate Lymphatic Filariasis.
    Wkly Epidemiol Rec; 2006 Jun; 81(22):221-32. PubMed ID: 16749186
    [No Abstract]   [Full Text] [Related]  

  • 29. Progress towards, and challenges for, the elimination of filariasis from Pacific-island communities.
    Burkot TR; Taleo G; Toeaso V; Ichimori K
    Ann Trop Med Parasitol; 2002 Dec; 96 Suppl 2():S61-9. PubMed ID: 12625919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Towards elimination of lymphatic filariasis: social mobilization issues and challenges in mass drug administration with anti-filarial drugs in Tamil Nadu, South India.
    Nandha B; Krishnamoorthy K; Jambulingam P
    Health Educ Res; 2013 Aug; 28(4):591-8. PubMed ID: 23503571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eliminating lymphatic filariasis--the surveillance challenge.
    Huppatz C; Durrheim D; Lammie P; Kelly P; Melrose W
    Trop Med Int Health; 2008 Mar; 13(3):292-4. PubMed ID: 18397392
    [No Abstract]   [Full Text] [Related]  

  • 32. Elimination of lymphatic filariasis.
    Wkly Epidemiol Rec; 2002 May; 77(22):177-9. PubMed ID: 12061029
    [No Abstract]   [Full Text] [Related]  

  • 33. The Global Programme to Eliminate Lymphatic Filariasis: health impact during its first 8 years (2000-2007).
    Hooper PJ; Bradley MH; Biswas G; Ottesen EA
    Ann Trop Med Parasitol; 2009 Oct; 103 Suppl 1():S17-21. PubMed ID: 19843394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing progress in reducing the at-risk population after 13 years of the global programme to eliminate lymphatic filariasis.
    Hooper PJ; Chu BK; Mikhailov A; Ottesen EA; Bradley M
    PLoS Negl Trop Dis; 2014 Nov; 8(11):e3333. PubMed ID: 25411843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolution of the monitoring and evaluation strategies to support the World Health Organization's Global Programme to Eliminate Lymphatic Filariasis.
    Lammie PJ; Gass KM; King J; Deming MS; Addiss DG; Biswas G; Ottesen EA; Henderson R
    Int Health; 2020 Dec; 13(Suppl 1):S65-S70. PubMed ID: 33349883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphatic filariasis.
    Wkly Epidemiol Rec; 2001 May; 76(20):149-54. PubMed ID: 11395916
    [No Abstract]   [Full Text] [Related]  

  • 37. Knowledge on lymphatic filariasis and mass drug administration (MDA) programme in filaria endemic districts of Andhra Pradesh, India.
    Mukhopadhyay AK; Patnaik SK; Satya Babu P; Rao KN
    J Vector Borne Dis; 2008 Mar; 45(1):73-5. PubMed ID: 18399322
    [No Abstract]   [Full Text] [Related]  

  • 38. Lymphatic filariasis in the Eastern Mediterranean Region: current status and prospects for elimination.
    El Setouhy M; Ramzy RM
    East Mediterr Health J; 2003 Jul; 9(4):534-41. PubMed ID: 15748050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, India.
    Babu BV; Kar SK
    Trop Med Int Health; 2004 Jun; 9(6):702-9. PubMed ID: 15189460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Global elimination of lymphatic filariasis.
    Wkly Epidemiol Rec; 2001 Dec; 76(50):396-8. PubMed ID: 11797238
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.